
Po-chih Chen
Examiner (ID: 15962, Phone: (571)270-7243 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1626 |
| Total Applications | 947 |
| Issued Applications | 619 |
| Pending Applications | 116 |
| Abandoned Applications | 237 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16512826
[patent_doc_number] => 20200392084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => SULFASALAZINE SALT COMPOSITIONS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/753971
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16753971
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/753971 | SULFASALAZINE SALT COMPOSITIONS AND METHODS OF USING THE SAME | Oct 8, 2018 | Abandoned |
Array
(
[id] => 15573979
[patent_doc_number] => 10577356
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Beta-arrestin-biased cannabinoid CB
[patent_app_type] => utility
[patent_app_number] => 16/153180
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 16603
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153180
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/153180 | Beta-arrestin-biased cannabinoid CB | Oct 4, 2018 | Issued |
Array
(
[id] => 16374978
[patent_doc_number] => 20200323820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => MATERIALS AND METHODS FOR INHIBITING TUMOR GROWTH
[patent_app_type] => utility
[patent_app_number] => 16/652973
[patent_app_country] => US
[patent_app_date] => 2018-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652973
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652973 | Materials and methods for inhibiting tumor growth | Oct 1, 2018 | Issued |
Array
(
[id] => 16282715
[patent_doc_number] => 20200276317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => PROTEIN COMPLEX COMPRISING NON-PEPTIDYL POLYMER-COUPLED FATTY ACID DERIVATIVE COMPOUND AS LINKER AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/647115
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647115
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647115 | Protein complex comprising non-peptidyl polymer-coupled fatty acid derivative compound as linker and preparation method therefor | Sep 30, 2018 | Issued |
Array
(
[id] => 14102225
[patent_doc_number] => 20190092788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => NOVEL RAPAMYCIN DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/141856
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16141856
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/141856 | Rapamycin derivatives | Sep 24, 2018 | Issued |
Array
(
[id] => 16970467
[patent_doc_number] => 11066428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Bis-phenyl-phenoxy polyolefin catalysts having a methylenetrialkylsilicon ligand on the metal for improved solubility
[patent_app_type] => utility
[patent_app_number] => 16/646228
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13772
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646228
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646228 | Bis-phenyl-phenoxy polyolefin catalysts having a methylenetrialkylsilicon ligand on the metal for improved solubility | Sep 19, 2018 | Issued |
Array
(
[id] => 17938346
[patent_doc_number] => 11472787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Docosahexaenoic acid endocannabinoid epoxide derivative compositions
[patent_app_type] => utility
[patent_app_number] => 16/648945
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 13999
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648945
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648945 | Docosahexaenoic acid endocannabinoid epoxide derivative compositions | Sep 19, 2018 | Issued |
Array
(
[id] => 16222661
[patent_doc_number] => 20200247777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => DERIVATIVES OF EPA ENDOCANNABINOID EPOXIDES AS ANTI-INFLAMMATORY, ANTI-CANCEROUS, ANTI-ANGIOGENC AND ANTIPLATELET AGGREGATION COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/648953
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648953 | Derivatives of EPA endocannabinoid epoxides as anti-inflammatory, anti-cancerous, anti-angiogenc and antiplatelet aggregation compounds | Sep 19, 2018 | Issued |
Array
(
[id] => 16970528
[patent_doc_number] => 11066489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Bis-phenyl-phenoxy polyolefin catalysts having two methylenetrialkylsilicon ligands on the metal for improved solubility
[patent_app_type] => utility
[patent_app_number] => 16/646237
[patent_app_country] => US
[patent_app_date] => 2018-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8623
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646237
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646237 | Bis-phenyl-phenoxy polyolefin catalysts having two methylenetrialkylsilicon ligands on the metal for improved solubility | Sep 18, 2018 | Issued |
Array
(
[id] => 16268729
[patent_doc_number] => 20200270216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING N-SMASE2
[patent_app_type] => utility
[patent_app_number] => 16/647364
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647364
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647364 | COMPOSITIONS AND METHODS FOR INHIBITING N-SMASE2 | Sep 13, 2018 | Abandoned |
Array
(
[id] => 16539267
[patent_doc_number] => 20200405680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => TRANSDERMAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/646717
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646717
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646717 | TRANSDERMAL FORMULATIONS | Sep 13, 2018 | Abandoned |
Array
(
[id] => 14518945
[patent_doc_number] => 10336719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/129867
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79595
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16129867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/129867 | 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors | Sep 12, 2018 | Issued |
Array
(
[id] => 14018833
[patent_doc_number] => 20190071410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => 3-Phenyl-7-Hydroxy-Isocoumarins as Macrophage Migration Inhibitory Factor (MIF) Inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/129944
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16129944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/129944 | 3-Phenyl-7-Hydroxy-Isocoumarins as Macrophage Migration Inhibitory Factor (MIF) Inhibitors | Sep 12, 2018 | Abandoned |
Array
(
[id] => 14684767
[patent_doc_number] => 20190241498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => RESVERATROL ESTERS
[patent_app_type] => utility
[patent_app_number] => 16/125574
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125574
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/125574 | RESVERATROL ESTERS | Sep 6, 2018 | Abandoned |
Array
(
[id] => 16328340
[patent_doc_number] => 20200299306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => COMPOUNDS WITH A BENZO[A]CARBAZOLE STRUCTURE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/645267
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1083
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645267
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645267 | COMPOUNDS WITH A BENZO[A]CARBAZOLE STRUCTURE AND USE THEREOF | Sep 3, 2018 | Abandoned |
Array
(
[id] => 20319334
[patent_doc_number] => 12457898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Organic compound, composition, organic optoelectronic device, and display device
[patent_app_type] => utility
[patent_app_number] => 16/630893
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7970
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 306
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630893 | Organic compound, composition, organic optoelectronic device, and display device | Sep 3, 2018 | Issued |
Array
(
[id] => 18187496
[patent_doc_number] => 11578065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Organic electroluminescence device
[patent_app_type] => utility
[patent_app_number] => 16/646980
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 36
[patent_no_of_words] => 10543
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 363
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646980
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646980 | Organic electroluminescence device | Sep 3, 2018 | Issued |
Array
(
[id] => 18597123
[patent_doc_number] => 20230271915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => SYNTHETIC DERIVATIVES OF OLEOYL-LYSOPHOSPHATIDYLINOSITOL (OLEOYL-LPI) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/643165
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643165
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643165 | SYNTHETIC DERIVATIVES OF OLEOYL-LYSOPHOSPHATIDYLINOSITOL (OLEOYL-LPI) AND USES THEREOF | Aug 30, 2018 | Pending |
Array
(
[id] => 16595809
[patent_doc_number] => 20210022340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => USE OF PYRIDINE UREA COMPOUND HAVING SNAIL-KILLING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/755036
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755036
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755036 | USE OF PYRIDINE UREA COMPOUND HAVING SNAIL-KILLING ACTIVITY | Aug 29, 2018 | Abandoned |
Array
(
[id] => 16299223
[patent_doc_number] => 20200284946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => ORGANIC OPTICAL MATERIAL
[patent_app_type] => utility
[patent_app_number] => 16/641112
[patent_app_country] => US
[patent_app_date] => 2018-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641112
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641112 | ORGANIC OPTICAL MATERIAL | Aug 23, 2018 | Pending |